© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
Solid Tumors
Keytruda Approved for Early Treatment of Colorectal Cancer in Patients With Genetic Mutations
June 30, 2020
FDA approves Merck's Keytruda for certain patients with metastatic colorectal cancer a month after study results were presented at ASCO.
Payers Should Take Action on Rising NSCLC Costs
November 29, 2019
A new report outlines the sharp cost increase associated with a NSCLC drug’s move from second-line to first-line treatment, and suggests payers work with manufacturers to address treatment pricing.
Chemotherapy Remains Significant for Cancer Treatment
November 29, 2019
Chemotherapy may be the “boomer” to millennial-esque new cancer treatments, but there is a reason the old standard became that way, and isn’t likely to be replaced anytime soon.
Personalized Treatments Could Increase Value of Cancer Care
November 25, 2019
There are a lot of ideas about ways to increase the value of cancer care, but personalized treatments may be the most significant and immediate.
Collaboration Key to a Holistic Model of Cancer Care
November 25, 2019
A holistic approach provides value and creates plans that support the wide-ranging needs of cancer patients and their families.
Radiation Oncology Model: What You Need to Know
November 04, 2019
As the proposed Radiation Oncology Model innovative payment model looms on the horizon, Anne Hubbard, director of health policy for the American Society for Radiation Oncology, talks about the main elements and complex finer points of the model, as well as what it will take for its success.
Altering Drug Dosages Can Benefit Patient’s Pockets
October 31, 2019
Researchers suggest changing cancer drug regimens could save money without sacrificing quality.
Planning For Oncology Care Model 2.0 is Underway
October 30, 2019
Proposed as an alternative to CMS’ Oncology Care Model, the Community Oncology Alliance is developing its Oncology Care Model 2.0 with the hopes of creating a better, more efficient payment and treatment system for cancer care.
Accurate Response Assessments Vital to Cancer Treatments
October 30, 2019
In order to develop more effective cancer treatments, researchers are turning to precision medicine to evaluate patient tumor responses.
Managing the Financial Fallout of Cancer Care
October 12, 2019
The high cost of targeted cancer therapies creates a “financial toxicity” for patients that has crippling effects.